News

Clínic Barcelona

Research April 29 2022

The Lancet Neurology selects a study from the Clínic-IDIBAPS among the most relevant published during the 20-year history of the journal

The publication collects the latest advances in neurology since 2002 and in the commemoration of its twentieth anniversary highlights the guidelines1

Clínic Barcelona

Research April 7 2022

COVID-19 vaccines are not associated with the onset of autoimmune neurological disorders

The analysis of two cohorts from the United Kingdom and Catalonia concluded that at least one dose of vaccine does not increase the risk of suffering1

Clínic Barcelona

Research March 10 2022

Researchers propose a new biomarker that may be key in the diagnosis of psychotic outbreaks

Researchers from the Hospital Clínic-IDIBAPS, the Research Institute of the Hospital de Sant Pau – IIB Sant Pan and the CIBERER confirm that the mole1

Clínic Barcelona

Research June 15 2021

Clínic-IDIBAPS researchers identify a new autoimmune encephalitis

For the first time it has been confirmed that some patients with autoimmune encephalitis of unknown origin produce autoantibodies against a subunit o1

Clínic Barcelona

Institutional June 6 2021

Amaia Muñoz Lopetegi awarded the AEA Community Seed Grant from the Autoimmune Encephalitis Alliance

Amaia Muñoz Lopetegi, a researcher in the Pathogenesis of autoimmune neuronal disorders group has been awarded the AEA Community Seed Grant from the1

5 5

page1
page2
page3
page4
page5 , current page.

News

The Lancet Neurology selects a study from the Clínic-IDIBAPS among the most relevant published during the 20-year history of the journal

COVID-19 vaccines are not associated with the onset of autoimmune neurological disorders

Researchers propose a new biomarker that may be key in the diagnosis of psychotic outbreaks

Clínic-IDIBAPS researchers identify a new autoimmune encephalitis

Amaia Muñoz Lopetegi awarded the AEA Community Seed Grant from the Autoimmune Encephalitis Alliance

navigation between pages below